M-cadherin Inhibitors

Common M-cadherin Inhibitors include, but are not limited to Y-27632, free base CAS 146986-50-7, PD 98059 CAS 167869-21-8, LY 294002 CAS 154447-36-6, DAPT CAS 208255-80-5 and U-0126 CAS 109511-58-2.

M-cadherin, a member of the cadherin superfamily, is a calcium-dependent cell adhesion molecule primarily expressed in muscle tissues. Cadherins are integral membrane proteins responsible for mediating cell-cell adhesion and are crucial for maintaining tissue architecture and integrity. The unique specificity of cadherins to bind homotypically to cadherins of the same type on adjacent cells allows them to play pivotal roles in various cellular processes, including tissue morphogenesis, cellular differentiation, and maintaining tissue homeostasis. M-cadherin, in particular, is predominantly associated with the myogenic lineage, where it is implicated in the fusion of myoblasts during the formation of multinucleated myotubes, a fundamental step in muscle tissue development and regeneration.

M-cadherin inhibitors are compounds designed to modulate the activity or expression of M-cadherin. These inhibitors can exert their effect by directly binding to M-cadherin, thereby preventing its interaction with other M-cadherin molecules on neighboring cells. This disruption can lead to altered cell adhesion dynamics, especially in muscle tissues where M-cadherin is prominently expressed. Additionally, M-cadherin inhibitors might act by influencing intracellular signaling pathways associated with M-cadherin, thus indirectly modulating its function. Given the role of M-cadherin in myoblast fusion and muscle tissue formation, these inhibitors can be vital tools for researchers aiming to understand the intricate processes of muscle development, regeneration, and related cellular dynamics. By providing a means to dissect the role of M-cadherin in these processes, such inhibitors contribute to a comprehensive understanding of muscle cell biology and tissue morphogenesis.